A peelable, lightweight film, developed by UT Austin professor Maria Croyle, can preserve live viruses, bacteria and antibodies without refrigeration. Credit: The University of Texas at Austin.
Access to vaccines around the world could get easier thanks to scientists in the College of Pharmacy at The University of Texas at Austin who have developed an inexpensive and innovative vaccine delivery method that preserves live viruses, bacteria, antibodies and enzymes without refrigeration.
Maria A. Croyle and her research team in the lab of the Division of Molecular Pharmaceutics and Drug Delivery at UT Austin have released a research paper describing a peelable lightweight film that stabilizes biologics and withstands extreme temperature changes. The technology has already demonstrated proof of concept for model Ebola and H1N1 vaccines, and it may prove to be an effective method of delivery for future treatments of pathogens such as the coronavirus that causes COVID-19.
“It is essentially a plug and play platform,” said Croyle, who is the Glaxo Wellcome Endowed Professor of Pharmaceutics at UT. “Once we know the specific qualities of a vaccine candidate, we can adapt the film’s components to meet those requirements, suspending and sealing it within the film matrix in a way that allows it to withstand extreme temperature changes and release the vaccine components in a precise and controlled manner.”
The research team published its findings in the journal Science Advances.
As researchers develop vaccines and biologic treatments for deadly diseases, a second challenge comes in distributing those treatments to remote, developing and low-income areas around the world. More than half of the leading causes of death in low-income countries were the result of infectious disease, while costs associated with storage and shipping vaccines and biological drugs make up 40% of the cost of drugs in the Western world.
Croyle’s film is not only inexpensive, but nearly one-thousandth the size of traditional vaccine vials and requires no refrigeration throughout the delivery and administration process. The technology could significantly increase the survival rates for existing preventable diseases and drastically reduce the timetable and cost to combat emerging diseases before they spread worldwide.
The film technology developed by Croyle has been licensed to a new startup company based in Chapel Hill, North Carolina. Early investors include the founders of Asklepios BioPharmaceutical Inc. (AskBio). The company was established to develop the film technology for applications in stabilizing biological therapeutics, such as vaccines, anti-infective and chemotherapeutic agents, and gene therapy products.
“We are excited to partner with AskBio to develop Maria’s platform technology,” said Erin Overstreet, director of licensing in UT Austin’s Office of Technology Commercialization. “We believe the technology is poised to help patients with rare diseases, with the potential to help many other patients as well, and look forward to seeing the technology benefit the public.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Vaccine delivery method
- Opinion: To deliver a COVID-19 vaccine equitably, we must start planning nowon May 7, 2020 at 2:24 pm
We will need political commitment and wisdom to ensure that a coronavirus vaccine is delivered globally and equitably, writes PATH's Deborah Atherly. This op-ed outlines a number of factors that will ...
- Gene Vaccineon May 5, 2020 at 11:12 am
Harvard Medical School researchers based at Massachusetts Eye and Ear and Massachusetts General Hospital are announcing progress towards the testing and development of an experimental vaccine called ...
- German DNA Vaccine Market Analysis 2020, Featuring Profiles of Market Players Eli Lilly, GE Healthcare, Merck and Novartison May 5, 2020 at 2:03 am
The "Germany DNA Vaccine Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. Germany is Europe's largest.
- Profits and Pride at Stake, the Race for a Vaccine Intensifieson May 2, 2020 at 3:36 pm
Governments, companies and academic labs are accelerating their efforts amid geopolitical crosscurrents, questions about safety and the challenges of producing enough doses for billions of people.
- With pressure growing, global race for a vaccine intensifieson May 2, 2020 at 2:51 pm
Four months after a mysterious new virus began its deadly march around the globe, the search for a vaccine has taken on an intensity never before seen in medical research, with huge implications for ...
Go deeper with Google Headlines on:
Vaccine delivery method
Go deeper with Bing News on:
Vaccine delivery without refrigeration
- Tall order: Find a vaccine; then, produce 300 million vials of iton May 1, 2020 at 5:07 am
The White House is developing a plan, called Operation Warp Speed, to accelerate vaccine production and try to get manufacturing capacity set up in advance of a vaccine approval.
- Find a Vaccine. Next: Produce 300 Million Vials of It.on May 1, 2020 at 2:09 am
Scaling up the manufacturing of syringes and other medical products required to deliver a vaccine to millions of Americans will be just as important as the vaccine itself.
- Prevention and Control of Influenza With Vaccineson April 26, 2020 at 5:00 pm
Precautions*: Moderate to severe acute illness with or without fever ... Quadrivalent is administered using the delivery system included with the vaccine. †† Age indication per package ...
- The success of a Covid-19 vaccine will hinge on its deliveryon April 25, 2020 at 4:08 am
It's not enough to make a new vaccine against SARS-CoV-2, the virus that causes Covid-19. We must also figure out in advance how to deliver it to people.
- Nanoengineers are using plant virus to develop COVID-19 vaccineon April 21, 2020 at 11:22 pm
To really make an impact, we are making a vaccine that's stable at room temperature and above so it can be shipped--without refrigeration ... will work on vaccine delivery devices in the form ...